Cerebrolysin vs DSIP
Overview
Cerebrolysin is primarily a cognitive enhancement peptide, while DSIP is used for sleep & recovery.
This page compares Cerebrolysin and DSIP across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Cerebrolysin | DSIP | |
|---|---|---|
| Category | Cognitive Enhancement | Sleep & Recovery |
| Regulatory status (US) | Research use only | Compounding (Rx) — Apr 2026 |
| Typical dosage | 5-10 ml | 100-300 mcg |
| Frequency | multiple times weekly | before bed |
| Reported benefits | Neuroprotection, stroke recovery support, cognitive improvement, neurodegenerative disease support | Improved deep sleep, stress reduction, recovery enhancement, pain reduction |
| Reported side effects | Generally well-tolerated. Possible: dizziness, agitation | Very well-tolerated, possible grogginess |
Key differences
Primary use. Cerebrolysin is categorised under Cognitive Enhancement, while DSIP falls under Sleep & Recovery. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Cerebrolysin: not FDA-approved; treated as a research compound. DSIP: not FDA-approved; compounding permitted with a prescription as of April 2026.
Dosing. Cerebrolysin is typically dosed at 5-10 ml (multiple times weekly). DSIP is typically dosed at 100-300 mcg (before bed).
Can you stack them?
Some protocols combine peptides, but stacking Cerebrolysin and DSIP has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Cerebrolysin and DSIP?
- Cerebrolysin is primarily a cognitive enhancement peptide, while DSIP is used for sleep & recovery. Cerebrolysin is not FDA-approved; generally classified as a research compound, whereas DSIP is not FDA-approved; compounding permitted with a prescription (as of April 2026).
- What is Cerebrolysin used for?
- Neuroprotection, recovery.
- What is DSIP used for?
- Delta sleep-inducing peptide.
- Can you take Cerebrolysin and DSIP together?
- Some users combine peptides within a single protocol, but stacking Cerebrolysin and DSIP has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Cerebrolysin or DSIP FDA-approved?
- Cerebrolysin is not FDA-approved; generally classified as a research compound. DSIP is not FDA-approved; compounding permitted with a prescription (as of April 2026).
Read the full articles
- Cerebrolysin — full monograph: mechanism, research, dosing & references
- DSIP — full monograph: mechanism, research, dosing & references